Optellum

Optellum Optellum’s vision is to radically reshape cancer care from early diagnosis to treatment.

Optellum’s vision is to radically reshape cancer care, by enabling every clinician to choose the optimal diagnostic and treatment pathway for their patient. We do that by providing expert-level decision support for personalised diagnosis and treatment, based on collective experience of thousands of doctors, pooled by applying Machine Learning to vast medical image and patient record repositories. Our first suite of products targets patient risk stratification for lung cancer – the world’s deadliest and commonest cancer – from early diagnosis through to treatment. We are a team of award-winning AI and imaging experts who met at Oxford’s world-renowned computer vision laboratory, and we have track records of bringing innovation to market (including multiple trade sales, IPO). We are backed by an Advisory Board comprising world-leading clinicians and experts in deep learning and diagnostic imaging; and Oxford's most prominent investors with track records in medtech startups.

This International Women's Day we're launching our Q&A with our investor Dr Tara Bishop of Black Opal Ventures, taking a...
08/03/2024

This International Women's Day we're launching our Q&A with our investor Dr Tara Bishop of Black Opal Ventures, taking about the collision of healthcare and technology and what inspires her to invest in companies like Optellum.

Introducing Dr Tara Bishop, Black Opal Ventures, and the Optellum Virtual Nodule Clinic. Part of our celebration of International Women's Day 2024.

Optellum's vision is to redefine early intervention of lung cancer, enabling every clinician, in every hospital, to make...
01/08/2023

Optellum's vision is to redefine early intervention of lung cancer, enabling every clinician, in every hospital, to make the right decisions and give patients the best chance to fight back.

Lung cancer is the #1 cancer killer.This we're launching our new video showing how Optellum can help clinicians with ...
01/08/2023

Lung cancer is the #1 cancer killer.

This we're launching our new video showing how Optellum can help clinicians with the only AI-based lung cancer clinical solution for early diagnosis.​​​​​​

An animated video (no voiceover) which explains how Optellum is addressing the problem of late stage diagnosis for lung cancer.

Are you a digital communications professional based in the UK with experience in and ? Are you a creative communicato...
08/06/2023

Are you a digital communications professional based in the UK with experience in and ? Are you a creative communicator who enjoys using technology to reach varied audiences of customers, partners and influencers across multiple channels? Would you like to work with a talented and dedicated team to make a difference in the fight against lung cancer?

We are looking for a part time (22.5 to 30 hours per week) Digital Communications and Marketing Officer to join our fantastic team working with Head of Communications and Marketing Rhiannon Lassiter. You will be based in our Oxford office with hybrid working arrangements.

Please visit our careers page for details and send your CV and a covering letter to hr@optellum.com explaining why you'd be a great fit for this role.

https://optellum.com/careers/

UK followers, please share with your own networks to help us find the new member of our team.

Optellum is a professional, expert, inclusive and international company with offices in the USA and in Oxford, UK.

Address

Oxford Centre For Innovation
Oxford
OX11BY

Website

Alerts

Be the first to know and let us send you an email when Optellum posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Early Interception of Lung Cancer

Optellum’s vision is to redefine cancer care, by enabling every clinician, in every hospital, to manage their patients in the optimal way.

We do that by providing end-end IT platform for personalized early diagnosis and therapy, based on the collective experience of thousands of doctors pooled by machine learning applied to vast patient datasets.

Our first suite of products targets management of patients at high risk of developing lung cancer – the world’s deadliest and commonest cancer – from early diagnosis through to treatment.

Optellum comprises a team of award-winning medical imaging software, AI, and clinical experts who met at Oxford’s world-renowned computer vision lab. Between us, we have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO. We are backed by an Advisory Board comprising world-leading clinicians and experts in deep learning ; and Oxford's most prominent investors.